Carle on Vermilion is a clinical research site located in Danville, Illinois, United States 61832.
Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.
Carle on Vermilion has participated in 102 clinical trials with 32 currently active.
Therapeutic areas: Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.
Sponsors: GOG Foundation, Gynecologic Oncology Group, ECOG-ACRIN Cancer Research Group.
Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Carle on Vermilion has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Carle on Vermilion has 102 clinical trials on record, with 32 currently active. Their work covers Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.
Carle on Vermilion has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.